Form 4: Guardant Health's Chief Medical Officer, Craig Eagle, Reports Stock Transactions
SEC Form 4 Filing
Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On May 15, 2025, Craig Eagle, the Chief Medical Officer of Guardant Health, Inc., engaged in transactions involving the company's common stock.
- He acquired 3,718 shares of common stock through the vesting of restricted stock units (RSUs).
- Simultaneously, 1,885 shares were withheld by the company to cover tax obligations related to the RSU vesting at a price of $40.46 per share.
- Following these transactions, Eagle directly owns 34,433 shares of Guardant Health common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions, with neutral sentiment.
Industry Context
This is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect routine executive compensation.
Key Dates
| Date | Description |
|---|---|
| 05/15/2022 | Initial vesting date of 25% of the restricted stock unit award. |
| 05/15/2025 | Date of the reported stock transactions: vesting of RSUs and tax withholding. |
| 05/16/2025 | Date of signature for the Form 4 filing. |
Keywords
Guardant Health, Craig Eagle, Form 4, Stock Transaction, Restricted Stock Units, Tax Withholding, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.